RSV Diagnostics Market, By Product (Kits and Assays and Instruments), By Method, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
RSV Diagnostics Market size was valued at USD 6,456.67 Billion in 2024, expanding at a CAGR of 5.87% from 2024 to 2032.
Respiratory Syncytial Virus (RSV) diagnostics focus on identifying RSV infections, primarily through respiratory specimens such as nasal or nasopharyngeal swabs. Common diagnostic methods include nucleic acid amplification tests (NAATs), particularly real-time PCR, which offer high sensitivity and specificity. Rapid antigen detection tests (RADTs) are also widely used for their speed, although they may be less accurate than molecular methods. Viral culture, while effective, is time-consuming and less frequently utilized in routine clinical settings. Accurate and timely diagnosis is essential for guiding treatment decisions, implementing infection control measures, and reducing the risk of complications—especially in high-risk groups like infants, older adults, and immunocompromised individuals. Testing is most reliable when performed within the first few days of symptom onset, when viral load is typically at its peak.
RSV Diagnostics Market- Market Dynamics
Rising Incidence of Respiratory Infections
The increasing prevalence of respiratory infections—especially among infants, the elderly, and immunocompromised individuals—is a key driver of growth in the RSV diagnostics market. Respiratory Syncytial Virus (RSV) is one of the most common causes of lower respiratory tract infections worldwide, contributing significantly to hospital admissions and healthcare expenditures. Timely and accurate diagnosis is essential for initiating appropriate treatment, preventing complications, and limiting the spread of infection.
Governments worldwide are recognizing the public health impact of RSV and are investing in enhanced surveillance programs and diagnostic infrastructure. For example, agencies such as the U.S. Centers for Disease Control and Prevention (CDC) and the European Centre for Disease Prevention and Control (ECDC) have prioritized funding for improved RSV detection and reporting systems. These initiatives, combined with rising awareness among healthcare professionals and broader access to diagnostic technologies, are driving increased testing rates. Together, these factors are fueling global demand for reliable, efficient, and rapid RSV diagnostic solutions.
RSV Diagnostics Market- Segmentation Analysis:
The global RSV Diagnostics Market is divided into Four categories: Product, Method, End User and Region.
The RSV diagnostics market is segmented by product into Kits and Assays, Instruments, and Other Products. Kits and Assays, which include reagents and test kits designed to detect RSV antigens or nucleic acids in patient samples, hold the dominant market share. These kits are essential for delivering rapid and accurate results, which are critical for timely clinical decision-making and effective patient management. Their convenience, ease of use, and continuous technological advancements have led to widespread adoption across hospitals, clinics, and diagnostic laboratories. According to the U.S. Centers for Disease Control and Prevention (CDC), the demand for rapid RSV testing kits increased by approximately 30% during recent RSV outbreak seasons, reflecting the growing reliance on these diagnostic tools. This surge has made Kits and Assays the largest revenue-generating segment within the RSV diagnostics market.
By end user, the RSV diagnostics market is divided into Hospitals and Clinics, Clinical Laboratories, and Home Care settings. Hospitals and Clinics represent the largest segment due to their frontline role in patient diagnosis and treatment, especially during peak RSV seasons when respiratory infections increase dramatically. These healthcare facilities manage a high volume of respiratory cases and require rapid, accurate diagnostic tools to control outbreaks and initiate immediate treatment. Clinical Laboratories, equipped with advanced diagnostic equipment and specialized personnel, provide testing services to multiple healthcare providers, while Home Care offers convenient at-home testing solutions for early detection outside traditional healthcare settings. According to the National Institutes of Health (NIH), over 70% of RSV diagnostic tests during peak seasons are conducted in hospital and clinic settings, underscoring their critical importance as the primary end users and driving demand for RSV diagnostic products in the market.
RSV Diagnostics Market- Geographical Insights
Geographically, the RSV Diagnostics Market spans North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with further segmentation by key countries driving business within these regions.
North America dominates the RSV diagnostics market, supported by its advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of innovative diagnostic technologies. The region faces a substantial burden of RSV infections, particularly among infants and elderly populations, which fuels demand for rapid and accurate testing solutions. Strong government support, comprehensive reimbursement policies, and the presence of leading industry players further bolster market growth. For instance, the U.S. government has increased funding through agencies like the CDC and NIH for respiratory infection surveillance and diagnostic innovation, reinforcing market expansion. Additionally, increasing awareness among healthcare professionals and patients about the critical importance of early RSV diagnosis continues to expand market penetration in North America.
Asia Pacific represents another major and fast-growing market for RSV diagnostics, driven by its large patient base and rising incidence of respiratory infections. Rapid urbanization, continuous improvements in healthcare infrastructure, and growing investments in medical facilities are accelerating the adoption of RSV diagnostic technologies. Key countries such as China, India, and Japan play a vital role in this growth, supported by government initiatives aimed at controlling infectious diseases. For example, governments across the region are increasing budgets for infectious disease control programs and expanding access to diagnostic tools in rural and underserved areas. Furthermore, enhanced awareness and improved access to diagnostic testing in both urban and rural areas contribute significantly to the expansion of the RSV diagnostics market across the Asia Pacific region.
RSV Diagnostics Market- Competitive Landscape:
The RSV diagnostics market is driven by established industry leaders and innovative new entrants focused on enhancing accuracy and rapid detection capabilities. Key players such as Abbott, Roche, Thermo Fisher Scientific, and Becton Dickinson dominate the market with a comprehensive portfolio of high-quality diagnostic kits, instruments, and assays. These companies invest heavily in research and development to improve test sensitivity, reduce turnaround times, and meet stringent regulatory requirements. Meanwhile, emerging companies are introducing novel molecular and point-of-care testing solutions, intensifying competition. This dynamic landscape fosters continuous innovation, broadening the adoption of RSV diagnostics across hospitals, clinics, and laboratories worldwide, ultimately improving the management of respiratory infections globally.
Recent Developments:
- In April 2024, Abbott launched a next-generation point-of-care molecular test for RSV and influenza, offering faster and more accurate diagnosis of respiratory infections to support improved patient outcomes across diverse clinical settings.
- In June 2023, Becton Dickinson (BD) completed the sale of its surgical instruments and laparoscopic instrumentation business to STERIS plc, streamlining its portfolio to focus more on core diagnostic and medical device segments.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RSV DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Biomérieux
- Becton, Dickinson and Company (BD)
- Abbott
- Roche
- Danaher
- Thermo Fisher
- Biocartis
- Luminex
- Hologic
- Fast Track Diagnostics
- Others
GLOBAL RSV DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
- Kits and Assays
- Instruments
- Other Products
GLOBAL RSV DIAGNOSTICS MARKET, BY METHOD - MARKET ANALYSIS, 2019 - 2032
- Molecular Diagnostics
- Rapid Antigen Detection Tests
- Enzyme-Linked Immunosorbent Assays
- Immunofluorescence Assays
- Other Rapid Antigen Detection Tests
- Chromatographic Immunoassays
- Optical Immunoassays
- Other Methods
GLOBAL RSV DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
- Hospitals and Clinics
- Clinical Laboratories
- Home Care
GLOBAL RSV DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. RSV Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. RSV Diagnostics Market Snippet by Product
2.1.2. RSV Diagnostics Market Snippet by Method
2.1.3. RSV Diagnostics Market Snippet by End User
2.1.4. RSV Diagnostics Market Snippet by Country
2.1.5. RSV Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. RSV Diagnostics Key Market Trends
3.1. RSV Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. RSV Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. RSV Diagnostics Market Opportunities
3.4. RSV Diagnostics Market Future Trends
4. RSV Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. RSV Diagnostics Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. RSV Diagnostics Market Landscape
6.1. RSV Diagnostics Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. RSV Diagnostics Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
7.1.2. Kits and Assays
7.1.3. Instruments
7.1.4. Other Products
8. RSV Diagnostics Market – By Method
8.1. Overview
8.1.1. Segment Share Analysis, By Method, 2023 & 2032 (%)
8.1.2. Molecular Diagnostics
8.1.3. Rapid Antigen Detection Tests
8.1.3.1. Enzyme-Linked Immunosorbent Assays
8.1.3.2. Immunofluorescence Assays
8.1.3.3. Other Rapid Antigen Detection Tests
8.1.3.3.1. Chromatographic Immunoassays
8.1.3.3.2. Optical Immunoassays
8.1.4. Other Methods
9. RSV Diagnostics Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
9.1.2. Hospitals and Clinics
9.1.3. Clinical Laboratories
9.1.4. Home Care
10. RSV Diagnostics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. RSV Diagnostics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. RSV Diagnostics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. France
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.8.4. France Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.9.4. Italy Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Spain
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.10.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. United Kingdom
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.11.4. United Kingdom Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. Russia
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.12.3. Russia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Netherlands
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.13.3. Netherlands Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Sweden
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.14.3. Sweden Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. RSV Diagnostics Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. South Korea
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.9.4. South Korea Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.10.4. Japan Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. RSV Diagnostics Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. RSV Diagnostics Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Method, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- RSV Diagnostics Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Biomérieux
11.2.2. Becton, Dickinson and Company (BD)
11.2.3. Abbott
11.2.4. Roche
11.2.5. Danaher
11.2.6. Thermo Fisher
11.2.7. Biocartis
11.2.8. Luminex
11.2.9. Hologic
11.2.10. Fast Track Diagnostics
11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
